GW810781

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GW810781, covering 2013-02-21 to 2013-02-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients [Phase 2]